Microorganism Identification and Antimicrobial Susceptibility Test Automated ID/Ast System Biochemical Analyzer

Name: Microorganism Identification and Antimicrobial Susceptibility Test Automated ID/Ast System Biochemical Analyzer
Brand: Nanjing Long Medical Technology Co., Ltd.
SKU: 2250192855

Jiangsu, ChinaNanjing Long Medical Technology Co., Ltd.

US$5,000.00-9,000.00

1 set

Product specifications

Sample Type

Product profile

Customization

Available

Classification

Ast Analysis System

Type

Hematology Analyzer

Model NO.

MA120

Certification

Group

Middle-aged and Old

Product Name

Microbiological Ld/Ast Analysis System

Display

7 Inch Color LCD Display 800*480

Input Device

Touch Screen and Barcode Scanner

Interface

4*USB 2.0 Host, 1*RS232, WLAN

Transport Package

Standard Export Package

Specification

670 x570 x 760mm (L*W*H)

Trademark

LongMed

Origin

China

HS Code

9027899090

Production Capacity

10000000

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceSelf-branded

Nanjing Long Medical Technology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 10 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.81h

AI-Powered supplier vetting

SummaryNanjing Long Medical Technology Co., Ltd. is a China-based trading company established in 2016, with approximately 9–10 employees and a broad medical-equipment portfolio. It reports OEM service for well-known brands, ODM availability, multiple customization options, inventory capability, documented corrective-action and complaint-handling procedures, and quality assurance. Its stated lead time is within 15 working days in both peak and off-season periods. The supplier reports FDA China certification for all products and CE and FDA audit passage for most products, although the exact certificates and scope are not detailed. Financial-related records are present for 2023–2025, but the supplied fields do not provide assessable financial metrics. The supplier reports no new products in the past year, no available SDK, no overseas warehouses, branches, agents, or showrooms, and no participation in offline trade shows. Production capacity and verified customer cases are not sufficiently evidenced.

CertificationsThe company states that all products have been certified by FDA China, while most have passed CE and FDA certificate audits; CE is also listed as a sustainable development and product certification capability. The exact certificate documents, products covered, and validity periods are not provided, so the claimed coverage cannot be fully verified.

After-Sales capabilityThe company describes its products as having perfect after-service and reports clear procedures with followed records for customer complaints and corrective and preventive actions. Quality assurance is also stated, providing explicit evidence of structured post-sale and quality-response processes.

R&D capabilityThe supplier reports no new products during the past year and no available SDK, which are explicit limitations for recent product development and software-development support. It does provide ODM service, but this does not offset the stated lack of recent new products and SDK availability.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, and flexible customization, and also reports ODM service. These statements directly support a broad customization offering.